Report an error

Spotted something inaccurate in “MC4R Agonist Setmelanotide Cuts BMI in Hypothalamic Obesity Phase 3 Trial”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.